argenx SE
XBRU:ARGX
argenx SE
XBRU:ARGX
Price:
350.6 EUR
3.82%
Updated:
May 29, 2024
argenx SE
EPS (Diluted)
|
argenx SE
EPS (Diluted) Peer Comparison
Comparables:
PHARM
PRQR
QURE
MRUS
N
NAMS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
argenx SE
XBRU:ARGX
|
EPS (Diluted)
-$7
|
CAGR 3-Years
24%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Pharming Group NV
AEX:PHARM
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
13%
|
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
EPS (Diluted)
€0
|
CAGR 3-Years
27%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Uniqure NV
NASDAQ:QURE
|
EPS (Diluted)
-$6
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-10%
|
|
|
Merus NV
NASDAQ:MRUS
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is argenx SE's EPS (Diluted)?
EPS (Diluted)
-7.2
USD
-7.2
USD
Based on the financial report for Mar 31, 2024, argenx SE's EPS (Diluted) amounts to -7.2 USD.
What is argenx SE's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-36%
-36%
Over the last year, the EPS (Diluted) growth was 59%. The average annual EPS (Diluted) growth rates for argenx SE have been 24% over the past three years , -36% over the past five years .
You don't have any saved screeners yet
